FASEB J. Pierce now sold as Thermo Scientific
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Order Full text via Infotrieve
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Velasquez, M. T.
Right arrow Articles by Michaelis, O. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Velasquez, M. T.
Right arrow Articles by Michaelis, O. E., 4th

The FASEB Journal, Vol 4, 2850-2859, Copyright © 1990 by The Federation of American Societies for Experimental Biology

REVIEWS

Animal models of spontaneous diabetic kidney disease

MT Velasquez, PL Kimmel and OE Michaelis 4th
Department of Medicine, George Washington University Medical Center, Washington, DC 20037.

Kidney disease, characterized by proteinuria and glomerular lesions, is a common complication of spontaneous diabetes mellitus in many animal species. It occurs in animals with hypoinsulinemia, hyperinsulinemia, or impaired glucose tolerance. The renal functional and structural abnormalities in spontaneously diabetic animals resemble human diabetic nephropathy in many respects. Mesangial expansion and glomerular basement membrane thickening, two structural hallmarks of diabetic glomerulopathy in humans, are the most frequently encountered lesions in animals. In addition, a nodular form of mesangial expansion that resembles but is not identical with human nodular glomerulosclerosis or the Kimmelstiel-Wilson lesion has been observed in some animal models. Other abnormalities, such as exudative hyaline lesions and arteriolar hyalinosis, have also been noted occasionally in other models. Although diabetic animals may develop kidney disease that resembles human diabetic nephropathy, no single animal model develops renal changes identical to those seen in humans. Nonetheless, animal models with spontaneous diabetic kidney disease may be useful for investigating the mechanisms of development of diabetic nephropathy and the effects of various treatment modalities on the progression of renal disease.


This article has been cited by other articles:


Home page
 DiabetesHome page
K.-M. Myint, Y. Yamamoto, T. Doi, I. Kato, A. Harashima, H. Yonekura, T. Watanabe, H. Shinohara, M. Takeuchi, K. Tsuneyama, et al.
RAGE Control of Diabetic Nephropathy in a Mouse Model: Effects of RAGE Gene Disruption and Administration of Low-Molecular Weight Heparin
Diabetes, September 1, 2006; 55(9): 2510 - 2522.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
E. Galkina and K. Ley
Leukocyte Recruitment and Vascular Injury in Diabetic Nephropathy
J. Am. Soc. Nephrol., February 1, 2006; 17(2): 368 - 377.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
A. Inada, K. Nagai, H. Arai, J.-i. Miyazaki, K. Nomura, H. Kanamori, S. Toyokuni, Y. Yamada, S. Bonner-Weir, G. C. Weir, et al.
Establishment of a Diabetic Mouse Model with Progressive Diabetic Nephropathy
Am. J. Pathol., August 1, 2005; 167(2): 327 - 336.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
M. D. Breyer, E. Bottinger, F. C. Brosius III, T. M. Coffman, R. C. Harris, C. W. Heilig, K. Sharma, and for the AMDCC
Mouse Models of Diabetic Nephropathy
J. Am. Soc. Nephrol., January 1, 2005; 16(1): 27 - 45.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
X. Qin, A. Goldfine, N. Krumrei, L. Grubissich, J. Acosta, M. Chorev, A. P. Hays, and J. A. Halperin
Glycation Inactivation of the Complement Regulatory Protein CD59: A Possible Role in the Pathogenesis of the Vascular Complications of Human Diabetes
Diabetes, October 1, 2004; 53(10): 2653 - 2661.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Ohashi, H. Abe, T. Takahashi, Y. Yamamoto, M. Takeuchi, H. Arai, K. Nagata, T. Kita, H. Okamoto, H. Yamamoto, et al.
Advanced Glycation End Products Increase Collagen-specific Chaperone Protein in Mouse Diabetic Nephropathy
J. Biol. Chem., May 7, 2004; 279(19): 19816 - 19823.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
E. M. Lee, C. A. Pollock, K. Drumm, J. A. Barden, and P. Poronnik
Effects of pathophysiological concentrations of albumin on NHE3 activity and cell proliferation in primary cultures of human proximal tubule cells
Am J Physiol Renal Physiol, October 1, 2003; 285(4): F748 - F757.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
K. Susztak, K. Sharma, M. Schiffer, P. McCue, E. Ciccone, and E. P. Bottinger
Genomic Strategies for Diabetic Nephropathy
J. Am. Soc. Nephrol., August 1, 2003; 14(90003): S271 - 278.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
K. Sharma, P. McCue, and S. R. Dunn
Diabetic kidney disease in the db/db mouse
Am J Physiol Renal Physiol, June 1, 2003; 284(6): F1138 - F1144.
[Abstract] [Full Text] [PDF]

Home page
 Vet PatholHome page
M. Maeda, A. Yabuki, S. Suzuki, M. Matsumoto, K. Taniguchi, and H. Nishinakagawa
Renal Lesions in Spontaneous Insulin-dependent Diabetes Mellitus in the Nonobese Diabetic Mouse: Acute Phase of Diabetes
Vet. Pathol., March 1, 2003; 40(2): 187 - 195.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
Y. SEGEV, D. LANDAU, R. RASCH, A. FLYVBJERG, and M. PHILLIP
Growth Hormone Receptor Antagonism Prevents Early Renal in Nonobese Diabetic Mice
J. Am. Soc. Nephrol., November 1, 1999; 10(11): 2374 - 2381.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1990 by The Federation of American Societies for Experimental Biology.